Lab-Grown Antivenom Shows Potential for Curing Black Mamba Snakebite
Antivenoms could one day be made in the lab instead of in animals. Researchers from…
05/10/2018 - 3 minutes
Denmark
Update: Non-Invasive Glucose Monitoring Device Moves Forward With Series B Funding
Update (10/09/2018): RSP Systems has raised an additional €3.85M that raises the total amount of…
10/09/2018 - 2 minutes
Collaboration Worth Over €1Bn Could Give Rise to New Cancer Immunotherapies
Genmab is partnering with the German company Immatics to develop immunotherapies directed against three cancer…
12/07/2018 - 2 minutes
A Biodegradable Plaster Could Help us Treat Mouth Ulcers
British researchers and a Danish biotech have joined forces to develop a polymer patch that…
25/06/2018 - 2 minutes
Danish Biotech Plans Phase II Study to Fight A Rare Eating Disorder
Saniona, a biotech focused on ion channel research, plans to test its lead candidate in…
11/06/2018 - 2 minutes
The Top 10 Biotech Companies in Copenhagen
The capital of one of the happiest countries in the world, Copenhagen has become a…
11/06/2018 - 7 minutes
Genmab and Janssen Suffer Combination Therapy Setback
Janssen will discontinue a Phase I study testing Danish biotech Genmab's blood cancer blockbuster daratumumab…
28/05/2018 - 2 minutes
Danish Biotech Raises Series A Round to Advance Microbe Engineering Technology
Biosyntia has raised €4M in Series A financing from Sofinnova Partners to bring its microbe engineering…
23/05/2018 - 2 minutes
Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes
BioLamina has partnered with Novo Nordisk to develop stem cell therapies for diabetes and other…
16/05/2018 - 2 minutes
A New Drug for Atrial Fibrillation Starts Human Testing in Europe
Update (14/03/2018): Acesion Pharma has started a Phase I clinical trial at the Centre for…
14/03/2018 - 2 minutes
Danish Biotech Starts Phase III Atopic Dermatitis Trial With Failed Asthma Treatment
Danish biotech LEO Pharma started a Phase III trial in atopic dermatitis with an antibody…
05/03/2018 - 2 minutes
Novo Holdings Pumps €135M into New Antibiotic Development to Fight Resistance
Novo Holdings has launched a $165M (€135M) impact fund to support companies that are developing…
28/02/2018 - 3 minutes
